Recent Updates
Recently added Catalysts
CRDL Positive Sentiment Score: 70/100

CARDIOL THERAPEUTICS INC. 602-2265 Upper Middle Road East, Oakville, ON, Canada, L6H 0G5 NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY GIVEN that an annual general meeting (the " Meeting ") of the hol

Key Takeaway: Cardiol Therapeutics Inc. has announced the schedule for its annual general meeting of shareholders, set to take place on June 24, 2026. Shareholders must return their proxies or votes 48 hours before the meeting. The company is utilizing an online format to facilitate participation and intends to distribute materials through electronic posting, reflecting a move towards sustainable practices. The record date for shareholder eligibility is set for May 7, 2026.

Market Sentiment Analysis

POSITIVE FACTORS

  • Annual general meeting scheduled, allowing shareholder engagement.
  • Use of electronic materials promotes environmental responsibility.
  • Reduction in costs for the corporation due to notice-and-access provisions.

Full Press Release Details

CARDIOL THERAPEUTICS INC.
602-2265 Upper Middle Road East,
Oakville, ON, Canada, L6H 0G5
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
NOTICE IS HEREBY GIVEN that an annual general
meeting (the "Meeting") of the holders (the "Shareholders") of all of the issued and outstanding
Class A common shares ("Common Shares") in the capital of Cardiol Therapeutics Inc. (the "Corporation"
or "Cardiol") will be held on June 24, 2026, at 4:30 p.m. (EDT) for the following purposes:
Shareholders must return their proxies or voting
instruction forms to intermediaries not later than 48 hours (excluding Saturdays, Sundays, and statutory holidays in the City of Toronto,
Ontario) prior to the time set for the Meeting or any adjournments or postponements thereof.
Cardiol is conducting an online only shareholders'
meeting. Registered Shareholders (as defined in the Circular) and duly appointed proxyholders can attend the meeting online at https://meetings.lumiconnect.com/400-405-294-535
where they can participate, vote, or submit questions during the meeting's live webcast.
Shareholders with questions regarding the virtual
Meeting portal or requiring assistance accessing the Meeting website may e-mail support-us@lumiglobal.com or helpdesk.us@lumiglobal.com
Website Where Meeting Materials are Posted
The management information circular ("Circular"),
financial statements of the Corporation for the year ended December 31, 2025 ("Financial Statements"), and management's
discussion and analysis of the Corporation's results of operations and financial condition for 2025 ("MD&A") may
be viewed online via the System for Electronic Document Analysis and Retrieval ("SEDAR+") at www.sedarplus.ca
or on the Corporation's website at www.cardiolrx.com.
Obtaining Paper Copies of Materials
Shareholders may also obtain paper copies of
the Circular, Financial Statements, and MD&A free of charge by contacting Odyssey Trust Company ("Odyssey"), via
www.odysseycontact.com or toll-free at 1-888-290-1175 or upon request to the Corporation's Corporate Secretary at 602-2265 Upper
Middle Road East, Oakville, ON, Canada, L6H 0G5, telephone (289) 910-0850.
A request for paper copies which are required
in advance of the Meeting should be sent so that they are received by the Corporation or Odyssey, as applicable, by June 10, 2026,
in order to allow sufficient time for Shareholders to receive the paper copies and to return their proxies or voting instruction forms
to intermediaries not later than 48 hours (excluding Saturdays, Sundays, and statutory holidays in the City of Toronto, Ontario) prior
to the time set for the Meeting or any adjournments or postponements thereof (the "Proxy Deadline").
The Corporation is utilizing the notice-and-access
mechanism (the "Notice-and-Access Provisions") under National Instrument 54-101 - Communication with Beneficial
Owners of Securities of a Reporting Issuer and National Instrument 51-102 - Continuous Disclosure Obligations, for distribution
of Meeting materials to registered and beneficial Shareholders. The Notice-and-Access Provisions allow reporting issuers to post electronic
versions of proxy-related materials (such as proxy circulars and annual financial statements) on-line, via SEDAR+, and on one other website,
rather than mailing paper copies of such materials to Shareholders. The Corporation anticipates that using notice-and-access for delivery
to all Shareholders will directly benefit the Corporation through a substantial reduction in both postage and material costs, and also
promote environmental responsibility by decreasing the large volume of paper documents generated by printing proxy-related materials.
The Corporation will not use procedures known
as "stratification" in relation to the use of Notice-and-Access Provisions. Stratification occurs when a reporting issuer using
the Notice-and-Access Provisions provides a paper copy of the Circular to some Shareholders with this notice package. In relation to the
Meeting, all Shareholders will receive the required documentation under the Notice-and-Access Provisions, which will not include a paper
copy of the Circular.
Shareholders with questions about notice-and-access
can call the Corporation's transfer agent, Odyssey, toll-free at 1-888-290-1175.
The Board of Directors of the Corporation has
fixed the close of business on May 7, 2026, as the record date (the "Record Date") for the purpose of determining
Shareholders entitled to receive notice of, and vote at, the Meeting. The failure of any Shareholder to receive notice of the Meeting
does not deprive such Shareholder of the right to vote at the Meeting. Only Shareholders of record at the close of business on May 7,
2026, are entitled to vote at the Meeting.
All Shareholders are invited to attend the Meeting
and may attend or may be represented by proxy. A "beneficial" or "non-registered" Shareholder will not be recognized
directly at the Meeting for the purposes of voting common shares registered in the name of his/her/its broker; however, a beneficial Shareholder
may attend the Meeting as proxyholder for a registered Shareholder and vote the common shares in that capacity. Only Shareholders as of
the Record Date are entitled to receive notice of and vote at the Meeting. Shareholders who are unable to attend the Meeting, or any adjournments
or postponements thereof, are requested to complete, date, and sign the form of proxy (registered holders) or voting instruction form
(beneficial holders).
SHAREHOLDERS ARE REMINDED TO REVIEW THE CIRCULAR
DATED at Oakville, Ontario, on this 7th
BY ORDER OF THE BOARD OF DIRECTORS
(signed) "David Elsley"
Director, President and Chief Executive Officer

Frequently Asked Questions

When is the annual meeting for Cardiol Therapeutics shareholders?

The annual meeting is on June 24, 2026, at 4:30 p.m. (EDT).

How can shareholders attend the meeting?

Shareholders can attend the meeting online at https://meetings.lumiconnect.com/400-405-294-535.

What materials are available for the annual meeting?

Shareholders can access the Circular and Financial Statements on SEDAR+ or Cardiol's website.

What is the deadline to request paper copies of meeting materials?

Requests for paper copies must be received by June 10, 2026.

Who is eligible to vote at the meeting?

Only Shareholders recorded by May 7, 2026, can vote at the meeting.

Last updated: May 26, 2026